Bnei-Zion Medical Center
Haifa 3339509
1 studies enrolling now · 13 studies all time
What they study most
Amyloidosis, B-Cell Chronic Lymphocytic Leukemia, B-cell Chronic Lymphocytic Leukemia, Brain Infarction, Cancer, Cerebral Ischemia, Chronic Hepatitis C, Follicular Lymphoma, Pediatric Growth Hormone Deficiency, Prostate Cancer Metastatic, Respiratory Syncytial Virus Infections, Stroke
Studies at this site
- Met Non Small Cell Cancer Registry (MOMENT) — Recruiting now
- Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
- Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children — Completed
- Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
- Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed
- Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis — Completed
- Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 — Completed
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients — Completed
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early